Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The combination of an increasing prevalence of diabetes and the aging of populations enables the appearance of a greater number of associated complications such as diabetic retinopathy. Diabetic retinopathy is the leading cause of preventable vision loss in working-age adults. The objective of this Special Issue is to highlight the existing evidence regarding the relationship between oxidative stress and low-grade chronic inflammation induced by hyperglycemia with the development and progression of diabetic retinopathy, with an emphasis on the importance of early diagnosis and the use of antioxidant and anti-inflammatory approaches to prevent or delay the harmful effects of diabetes on retinal tissue.

Medicine --- eicosanoids --- oxidative stress --- diabetic retinopathy --- cyclooxygenase --- lipoxygenase --- Cytochrome P450 --- HDAC6 --- tubastatin A --- retinal endothelial cells --- retinal endothelial cell senescence --- db/db mice --- Cinnamomi Ramulus --- Paeoniae Radix --- CPA4-1 --- blood-retinal barrier --- occludin --- human retina --- epiretinal membrane --- internal limiting membrane --- vitreoretinal surgery --- macular hole --- proliferative diabetic retinopathy --- antioxidants --- diabetes mellitus --- free radicals --- high-mobility group box 1 (HMGB1) --- inflammatory pathways --- novel therapies --- diabetic retinopathy (DR) --- inflammation --- angiogenesis --- extracellular vesicles --- miRNA --- biomarkers --- apoptosis --- fenofibrate --- thioredoxin --- hyperglycemia --- astaxanthin --- carotenoid --- reactive oxygen species --- photoreceptor cells --- PI3K --- Nrf2 --- eicosapentaenoic acid (EPA) --- docosahexaenoic acid (DHA) --- retinal pigment epithelium --- antioxidant --- ascorbic acid --- retinal disease --- vitamin D --- GLP-1 --- superoxide dismutase --- biomarkers of diabetic retinopathy --- metabolic memory --- tear film --- aqueous humor --- vitreous humor --- mitochondria --- redox --- photoreceptor --- glycation --- aging --- glyoxalase --- eicosanoids --- oxidative stress --- diabetic retinopathy --- cyclooxygenase --- lipoxygenase --- Cytochrome P450 --- HDAC6 --- tubastatin A --- retinal endothelial cells --- retinal endothelial cell senescence --- db/db mice --- Cinnamomi Ramulus --- Paeoniae Radix --- CPA4-1 --- blood-retinal barrier --- occludin --- human retina --- epiretinal membrane --- internal limiting membrane --- vitreoretinal surgery --- macular hole --- proliferative diabetic retinopathy --- antioxidants --- diabetes mellitus --- free radicals --- high-mobility group box 1 (HMGB1) --- inflammatory pathways --- novel therapies --- diabetic retinopathy (DR) --- inflammation --- angiogenesis --- extracellular vesicles --- miRNA --- biomarkers --- apoptosis --- fenofibrate --- thioredoxin --- hyperglycemia --- astaxanthin --- carotenoid --- reactive oxygen species --- photoreceptor cells --- PI3K --- Nrf2 --- eicosapentaenoic acid (EPA) --- docosahexaenoic acid (DHA) --- retinal pigment epithelium --- antioxidant --- ascorbic acid --- retinal disease --- vitamin D --- GLP-1 --- superoxide dismutase --- biomarkers of diabetic retinopathy --- metabolic memory --- tear film --- aqueous humor --- vitreous humor --- mitochondria --- redox --- photoreceptor --- glycation --- aging --- glyoxalase

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The combination of an increasing prevalence of diabetes and the aging of populations enables the appearance of a greater number of associated complications such as diabetic retinopathy. Diabetic retinopathy is the leading cause of preventable vision loss in working-age adults. The objective of this Special Issue is to highlight the existing evidence regarding the relationship between oxidative stress and low-grade chronic inflammation induced by hyperglycemia with the development and progression of diabetic retinopathy, with an emphasis on the importance of early diagnosis and the use of antioxidant and anti-inflammatory approaches to prevent or delay the harmful effects of diabetes on retinal tissue.

eicosanoids --- oxidative stress --- diabetic retinopathy --- cyclooxygenase --- lipoxygenase --- Cytochrome P450 --- HDAC6 --- tubastatin A --- retinal endothelial cells --- retinal endothelial cell senescence --- db/db mice --- Cinnamomi Ramulus --- Paeoniae Radix --- CPA4-1 --- blood-retinal barrier --- occludin --- human retina --- epiretinal membrane --- internal limiting membrane --- vitreoretinal surgery --- macular hole --- proliferative diabetic retinopathy --- antioxidants --- diabetes mellitus --- free radicals --- high-mobility group box 1 (HMGB1) --- inflammatory pathways --- novel therapies --- diabetic retinopathy (DR) --- inflammation --- angiogenesis --- extracellular vesicles --- miRNA --- biomarkers --- apoptosis --- fenofibrate --- thioredoxin --- hyperglycemia --- astaxanthin --- carotenoid --- reactive oxygen species --- photoreceptor cells --- PI3K --- Nrf2 --- eicosapentaenoic acid (EPA) --- docosahexaenoic acid (DHA) --- retinal pigment epithelium --- antioxidant --- ascorbic acid --- retinal disease --- vitamin D --- GLP-1 --- superoxide dismutase --- biomarkers of diabetic retinopathy --- metabolic memory --- tear film --- aqueous humor --- vitreous humor --- mitochondria --- redox --- photoreceptor --- glycation --- aging --- glyoxalase --- n/a